Tsigereda Weldemichael
Role not yet determined Is this you? Add your title
Also affiliated: Tianjin University (2022)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Tsigereda Weldemichael's research investigates mechanisms of drug delivery and therapeutic interventions, with a focus on kidney diseases and cancer. Her work includes studying the CD36-mediated endocytosis of proteolysis-targeting chimeras and the delivery efficiency of oligonucleotides using lipid conjugation. Weldemichael has also explored renoprotective approaches against anthracycline nephrotoxicity and the impact of specific compounds, such as EET-based therapeutics, on mitigating drug-induced cellular damage in the kidneys. Her recent publications also touch on synthetic biology applications and industrial uses of enzymes. Weldemichael collaborates with researchers at the University of Arkansas for Medical Sciences, including Abdul H. Khan and Phuc Tran, and at the University of Arkansas at Fayetteville, including Samaneh Goorani.
Metrics
- h-index: 5
- Publications: 8
- Citations: 146
Selected Publications
-
Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats (2026)
-
Renoprotective approaches against anthracycline nephrotoxicity (2026)
-
EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage (2025)
-
Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications (2025)
-
CD36-mediated endocytosis of proteolysis-targeting chimeras (2025)
-
An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L (2023)
-
Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome (2022)
Collaboration Network
Top Collaborators
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- Renoprotective approaches against anthracycline nephrotoxicity
- Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats
- EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage
- Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats
- EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage
- Renoprotective approaches against anthracycline nephrotoxicity
- Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- CD36-mediated endocytosis of proteolysis-targeting chimeras
Similar Researchers
Based on overlapping research topics